Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

Clinical Trial Title: 
Public health surveillance for the prevention of complications of bleeding and clotting disorders.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Lisa Boggio, MD
Clinical Trial Protocol Description: 

HIV and hepatitis C screening. Lab draws for testing inhibitors.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have hemophilia, von Willebrand disease, or another bleeding disorder.
  • Have received blood based product via infusion/transfusion.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Lisa Boggio, MD